Towards mimicking short linear peptide motifs: Identification of new mixed α,β-peptidomimetic ligands for SLAM-Associated Protein (SAP) by confocal on-bead screening

Journal of Chemical Biology

Volumn 5, Issue 2, 2012, Pages 63-79

  Hintersteiner, Martin ^a   Knox, Andrew J ^b   Mudd, Gemma ^c   Auer, Manfred ^c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Docking; One bead one compound; Peptidomimetics; SAP; Screening

Indexed keywords

PEPTIDOMIMETIC AGENT; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN;

ARTICLE; CHEMICAL MODIFICATION; COMBINATORIAL CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NATURAL KILLER CELL; PEPTIDE ANALYSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN STABILITY; T LYMPHOCYTE ACTIVATION;

EID: 84866108537     PISSN: 18646158     EISSN: 18646166     Source Type: Journal    
DOI: 10.1007/s12154-011-0071-9     Document Type: Article

References (26)

1. Chen G, Tai AK, Lin M, Chang F, Terhorst C, Huber BT (2007) Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death. Eur J Immunol 37(3):663-674
2. Chuang H-C, Lay J-D, Hsieh W-C, Wang H-C, Chang Y, Chuang S-E, Su I-J (2005) Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood 106(9):3090-3096
3. Dierck K, Machida K, Voigt A, Thimm J, Horstmann M, Fiedler W, Mayer BJ, Nollau P (2006) Quantitative multiplexed profiling of cellular signalling networks using phosphotyrosine-specific DNA-tagged SH2 domains. Nat Methods 3(9):737-744
4. Dong Z, Cruz-Munoz M-E, Zhong M-C, Chen R, Latour S, Veillette A (2009) Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat Immunol 10(9):973-980
5. Furukawa H, Tohma S, Kitazawa H, Komori H, Nose M, Ono M (2010) Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders. Arch Immunol Ther Exp 58(1):37-44
6. Gademann K, Hane A, Rueping M, Jaun B, Seebach D (2003) The fourth helical secondary structure of beta-peptides: the (P)-28-helix of a beta-hexapeptide consisting of (2R,3S)-3-amino-2-hydroxy acid residues. Angew Chem Int Ed 42(13):1534-1537
7. Hara T, Durell SR, Myers MC, Appella DH (2006) Probing the structural requirements of peptoids that inhibit HDM2-p53 interactions. J Am Chem Soc 128(6):1995-2004
8. Hintersteiner M, Buehler C, Uhl V, Schmied M, Muller J, Kottig K, Auer M (2009) Confocal nanoscanning, bead picking (CONA): PickoScreen microscopes for automated and quantitative screening of one-bead one-compound libraries. J Comb Chem 11(5):886- 894
9. Hintersteiner M, Kimmerlin T, Garavel G, Schindler T, Bauer R, Meisner N-C, Seifert J-M, Uhl V, Auer M (2009) A highly potent and cellularly active b-peptidic inhibitor of the p53/hDM2 interaction. Chembiochem 10(6):994-998
10. Hintersteiner M, Kimmerlin T, Kalthoff F, Stoeckli M, Garavel G, Seifert J-M, Meisner N-C, Uhl V, Buehler C, Weidemann T, Auer M (2009) Single bead labelling method for combining confocal fluorescence on-bead screening and solution validation of tagged one-bead one-compound libraries. Chem Biol 16(7):724-735
11. Hron JD, Caplan L, Gerth AJ, Schwartzberg PL, Peng SL (2004) SH2D1A regulates T-dependent humoral autoimmunity. J Exp Med 200(2):261-266
12. Hwang PM, Li C, Morra M, Lillywhite J, Muhandiram DR, Gertler F, Terhorst C, Kay LE, Pawson T, Forman-Kay JD, Li S-C (2002) A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome. EMBO J 21(3):314-323
13. Kaneko T, Huang T, Zhao B, Li L, Liu H, Voss CK, Wu C, Schiller MR, Shun-Cheng Li S (2010) Loops govern SH2 domain specificity by controlling access to binding pockets. Sci Signal 3(120):ra34
14. Kask P, Palo K, Fay N, Brand L, Mets U, Ullmann D, Jungmann J, Pschorr J, Gall K (2000) Two-dimensional fluorescence intensity distribution analysis: theory and applications. Biophys J 78 (4):1703-1713
15. Li S-C, Gish G, Yang D, Coffey AJ, Forman-Kay JD, Ernberg I, Kay LE, Pawson T (1999) Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/ SH2D1A. Curr Biol 9(23):1355-1362
16. Machida K, Mayer BJ (2005) The SH2 domain: versatile signaling module and pharmaceutical target. Biochimica et Biophysica Acta 1747(1):1-25
17. McCausland MM, Yusuf I, Tran H, Ono N, Yanagi Y, Crotty S (2007) SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase. J Immunol 178(2):817-828
18. Poy F, Yaffe MB, Sayos J, Saxena K, Morra M, Sumegi J, Cantley LC, Terhorst C, Eck MJ (1999) Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosineindependent sequence recognition. Mol Cell 4(4):555-561
19. Schreiber JV, Quadroni M, Seebach D (1999) Sequencing of bpeptides by mass spectrometry. Chimia 53(12):621-626
20. Seebach D, Abele S, Gademann K, Guichard G, Hintermann T, Jaun B, Matthews JL, Schreiber JV, Oberer L, Hommel U, Widmer H (1998) Beta 2- and beta 3-peptides with proteinaceous sidechains. Synthesis and solution structures of constitutional isomers, a novel helical secondary structure, and the influence of solvation and hydrophobic interactions on folding. Helvetica Chimica Acta 81(5):932-982
21. Seebach D, Beck AK, Bierbaum DJ (2004) The world of betaand gamma-peptides comprised of homologated proteinogenic amino acids and other components. Chem Biodivers 1(8):1111- 1239
22. Seebach D, Overhand M, Kuehnle FNM, Martinoni B (1996) b- Peptides. Synthesis by Arndt-Eistert homologation with concomitant peptide coupling. Structure determination by NMR and CD spectroscopy and by x-ray crystallography. Helical secondary structure of a b-hexapeptide in solution and its stability towards pepsin. Helvetica Chimica Acta 79(4):913-941
23. Seebach D, Rueping M, Arvidsson PI, Kimmerlin T, Micuch P, Noti C, Langenegger D, Hoyer D (2001) Linear, peptidaseresistant beta 2/beta 3-di- and alpha/beta 3-tetrapeptide derivatives with nanomolar affinities to a human somatostatin receptor preliminary communication. Helvetica Chimica Acta 84(11):3503- 3510
24. Sheinerman FB, Al-Lazikani B, Honig B (2003) Seq< uence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains. J Mol Biol 334(4):823- 841
25. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S (1993) SH2 domains recognize specific phosphopeptide sequences. Cell (Cambridge, MA, United States) 72(5):767-778
26. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H (1994) Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 14(4):2777-2785